Author

Jose M Rubio

Northwell Health - Feinstein Institute - Cited by 1,657 - Psychiatry

Biography

Jose M Rubio is working as professor in Department of Psychiatry, North Shore-Long Island Jewish Health System, New York, USA. Research experience includes various programs, contributions and participation in different countries for diverse fields of Childhood Anxiety, Depression, Mindfullness Based Therapy, Panic Attacks and Suicidal Thoughts.
Title
Cited by
Year
Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis
JM Rubio, G Schoretsanitis, M John, J Tiihonen, H Taipale, D Guinart, ...The Lancet Psychiatry 7 (9), 749-7, 2020202
61
2020
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times …
M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, ...Journal of affective disorders 299, 367-6, 2022202
37
2022
Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study
JM Rubio, H Taipale, CU Correll, A Tanskanen, JM Kane, J TiihonenPsychological Medicine 50 (8), 1356-1367, 2020202
32
2020
Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia
R Emsley, L Asmal, JM Rubio, CU Correll, JM KaneSchizophrenia research 225, 55-62, 2020202
30
2020
Long-term continuity of antipsychotic treatment for schizophrenia: a nationwide study
JM Rubio, H Taipale, A Tanskanen, CU Correll, JM Kane, J TiihonenSchizophrenia Bulletin 47 (6), 1611-1620, 2021202
28
2021
How and when to use clozapine
JM Rubio, JM KaneActa Psychiatrica Scandinavica 141 (3), 178-189, 2020202
26
2020
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting …
M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, ...Journal of affective disorders 299, 393-407, 202
22
2022
Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review
R de Filippis, P Soldevila-Matías, P De Fazio, D Guinart, I Fuentes-Durá, ...Expert Review of Clinical Pharmacology 13 (8), 875-883, 2020202
21
2020
A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome
D Guinart, F Misawa, JM Rubio, J Pereira, R de Filippis, C Gastaldon, ...Acta Psychiatrica Scandinavica 144 (4), 329-341, 2021202
17
2021
Risk factors, incidence, and outcomes of neuroleptic malignant syndrome on long-acting injectable vs oral antipsychotics in a nationwide schizophrenia cohort
D Guinart, H Taipale, JM Rubio, A Tanskanen, CU Correll, J Tiihonen, ...Schizophrenia Bulletin 47 (6), 1621-1630, 2021202
17
2021
Predictors of lack of relapse after random discontinuation of oral and long-acting injectable antipsychotics in clinically stabilized patients with schizophrenia: a re-analysis …
G Schoretsanitis, JM Kane, CU Correll, JM RubioSchizophrenia Bulletin 48 (2), 296-306, 2022202
17
2022
Candidate biomarkers in psychiatric disorders: state of the field
A Abi‐Dargham, SJ Moeller, F Ali, C DeLorenzo, K Domschke, G Horga, ...World Psychiatry 22 (2), 236-262, 2023202
13
2023
Precuneus and insular hypoactivation during cognitive processing in first-episode psychosis: systematic review and meta-analysis of fMRI studies
P Soldevila-Matías, A Albajes-Eizagirre, J Radua, G García-Martí, ...Revista de psiquiatria y salud mental 15 (2), 101-116, 2022202
13
2022
Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: a systematic review
R de Filippis, P Soldevila-Matías, D Guinart, P De Fazio, JM Rubio, ...Journal of Psychopharmacology 35 (9), 1062-1073, 2021202
11
2021
Outcomes of neuroleptic malignant syndrome with depot versus oral antipsychotics: a systematic review and pooled, patient-level analysis of 662 case reports
D Guinart, F Misawa, JM Rubio, J Pereira, H Sharma, G Schoretsanitis, ...The Journal of Clinical Psychiatry 82 (1), 13591, 2020202
10
2020
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis
F Ueno, Y Iwata, S Nakajima, F Caravaggio, JM Rubio, G Horga, ...Neuroscience & Biobehavioral Reviews 132, 1205-1213, 2022202
9
2022
Efficacy and acceptability of psychosocial interventions in schizophrenia: Systematic overview and quality appraisal of the meta-analytic evidence
M Solmi, G Croatto, G Piva, S Rosson, P Fusar-Poli, JM Rubio, ...Molecular Psychiatry 2 (1), 354-36, 2023202
8
2023
Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
JM Rubio, AK Malhotra, JM KaneBehavioural Brain Research 402, 113099, 2021202
6
2021
Striatal functional connectivity in psychosis relapse: A hypothesis generating study
JM Rubio, T Lencz, A Barber, A Moyett, S Ali, F Bassaw, G Ventura, ...Schizophrenia Research 243, 342-348, 2022202
5
2022
Using claims data to assess treatment quality of first-episode psychosis
C Reist, E Valdes, Y Ren, A Wright, JM RubioPsychiatric Services 72 (3), 247-23, 2021202
5
2021

Referred From: https://scholar.google.com/citations?user=DU5BWfAAAAAJ&hl=en

Cited by
Citations 1657
h-index 18
i10-index 30
Recommended Journals
Open Access Journals